Mebias Discovery Receives Grant from NIDA to Advance MEB 1170 as an Analgesic Drug Candidate for the Prevention and Treatment of Opioid Use Disorder
Mebias Discovery Receives Grant from NIDA to Advance MEB‑1170 as an Analgesic Drug Candidate for the Prevention and Treatment of Opioid Use Disorder
Grant to Fund IND Enabling and Phase 1 Clinical Trials
Preclinical Data Demonstrates MEB‑1170 Lacks Dangerous Side Effects Including Respiratory Depression and Opioid Abuse Potential
Comments are closed.